| Antirheumatic medications | ||
| Class | Generic name | Trade name |
| Traditional DMARDs | ||
| Antimetabolites | Azathioprine | Azasan, Imuran |
| Methotrexate | Rheumatrex, Trexall, Otrexup, Rasuvo | |
| Mycophenolate mofetil | CellCept | |
| Leflunomide | Arava | |
| T-cell/calcineurin inhibitor | Ciclosporin | Neoral, Gengraf, Sandimmune |
| Alkylating agent | Cyclophosphamide | |
| Aminosalicylate | Sulfasalazine | Azulfidine, Sulfazine |
| PDE4 inhibitor | Apremilast | Otezla |
| Janus kinase inhibitors | Baricitinib | Olumiant |
| Tofacitinib | Xeljanz | |
| Biologic DMARDs | ||
| TNF inhibitor—monoclonal antibody | Infliximab | Remicade |
| Adalimumab | Humira | |
| Golimumab | Simponi | |
| Certolizumab pegol | Cimzia | |
| TNF inhibitor—soluble TNF receptor fusion protein | Etanercept | Enbrel |
| IL-1 antagonist | Anakinra | Kineret |
| Canakinumab | Ilaris | |
| IL-6 antagonist | Sarilumab | Kevzara |
| Tocilizumab | Actemra | |
| IL-12, IL-23 inhibitor | Ustekinumab | Stelara |
| IL-17 inhibitor | Secukinumab | Consentyx |
| Ixekizumab | Taltz | |
| Antilymphocytic agents | Rituximab | Rituxan |
| Abatacept | Orencia | |
| Interferons | ||
| Interferon type 1 | Interferon alpha |
DMARD, disease-modifying antirheumatic drug; TNF, tumour necrosis factor.